[HTML][HTML] Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis

Y Lin, R Lin, HB Lin, S Shen - Medicine in Drug Discovery, 2024 - Elsevier
Atherosclerosis, a highly prevalent cardiovascular disease, has significantly contributed to
morbidity and mortality worldwide. Despite the availability of various treatment options in …

Current targeting strategies and advanced nanoplatforms for atherosclerosis therapy

Y Li, Q Feng, L Wang, X Gao, Y Xi, L Ye, J Ji… - Journal of Drug …, 2024 - Taylor & Francis
Atherosclerosis is one of the major causes of death worldwide, and it is closely related to
many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although …

Recent Advances in Anti‐Atherosclerosis and Potential Therapeutic Targets for Nanomaterial‐Derived Drug Formulations

Z Xiao, Y Li, L Xiong, J Liao, Y Gao, Y Luo… - Advanced …, 2023 - Wiley Online Library
Atherosclerosis, the leading cause of death worldwide, is responsible for≈ 17.6 million
deaths globally each year. Most therapeutic drugs for atherosclerosis have low delivery …

[HTML][HTML] Combating atherosclerosis with targeted nanomedicines: recent advances and future prospective

A Nakhlband, M Eskandani, Y Omidi, N Saeedi… - BioImpacts …, 2018 - ncbi.nlm.nih.gov
An external file that holds a picture, illustration, etc. Object name is bi-8-59-g004. jpg
Introduction: Cardiovascular diseases (CVDs) is recognized as the leading cause of …

Recent advances in inhibiting atherosclerosis and restenosis: From pathogenic factors, therapeutic molecules to nano-delivery strategies

X Wang, B Gao, Y Feng - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
Due to dominant atherosclerosis etiology, cardiovascular diseases (CVDs) remain the
leading cause of morbidity and mortality worldwide. In clinical trials, advanced …

Biomimetic nanoparticles targeting atherosclerosis for diagnosis and therapy

Y Li, J Wang, J Xie - Smart Medicine, 2023 - Wiley Online Library
Atherosclerosis is a typical chronic inflammatory vascular disease that seriously endangers
human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used …

Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis

L Ou, S Zhong, J Ou, J Tian - Acta Pharmacologica Sinica, 2021 - nature.com
Atherosclerosis (AS) is the main pathological cause of coronary heart disease (CHD).
Current clinical interventions including statin drugs can effectively reduce acute myocardial …

Atherosclerosis Treatment with Stimuli‐Responsive Nanoagents: Recent Advances and Future Perspectives

A Maruf, Y Wang, T Yin, J Huang… - Advanced …, 2019 - Wiley Online Library
Atherosclerosis is the root of approximately one‐third of global mortalities. Nanotechnology
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …

Nanotechnology for targeted therapy of atherosclerosis

S Hossaini Nasr, X Huang - Frontiers in Pharmacology, 2021 - frontiersin.org
Atherosclerosis is the major cause of heart attack and stroke that are the leading causes of
death in the world. Nanomedicine is a powerful tool that can be engineered to target …

Nanomedicine-based strategies for treatment of atherosclerosis

M Schiener, M Hossann, JR Viola… - Trends in molecular …, 2014 - cell.com
Atherosclerosis is a chronic inflammatory disease of the arterial wall that arises from an
imbalanced lipid metabolism and a maladaptive inflammatory response. Despite intensive …